Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Demographics of participants from seven focus groups

From: Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study

Characteristic

No. (%) (N = 28)

Sex

Male

11 (39.3)

Female

17 (60.7)

Race

White

27 (96.4)

Other

1 (3.6)

Ethnicity

Non- Hispanic

24 (85.7)

Hispanic

4 (14.3)

Age, years

18–29

4 (14.3)

30–39

12 (42.9)

40+

12 (42.9)

Level of Education

Some High School

1 (3.6)

High School graduate or GED equivalent

5 (17.9)

Some College

20 (71.4)

College Graduate

2 (7.1)

Employment Status

Unemployed

15 (53.7)

Part-time or temporary worker

4 (14.3)

Full-time Employee

9 (32.1)

Type of MOUD

Methadone

5 (17.9)

Naltrexone

3 (10.7)

Buprenorphine

2 (7.1)

Buprenorphine with Naloxone

18 (64.3)

Time on MOUD

0–3 months

8 (28.6)

4–9 months

6 (21.4)

10–12 months

3 (10.7)

≥ 1 year to < 2 years

5 (17.9)

≥ 2 years to < 3 years

2 (17.9)

  1. MOUD, Medication for opioid use disorder
  2. GED, General Educational Development